PETMED EXPRESS INC
For the period ended Mar 31, 2025. Filed Oct 14, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Oct 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accountant Fees and Services
The following table sets forth the fees billed to us by RSM US LLP as of and for the fiscal years ended March 31, 2025 and March 31, 2024:
| For the Year Ended March 31, | |||
|---|---|---|---|
| 2025 · 2024 | |||
| Audit fees | (1) | $1,621,723 | $700,140 |
| Audit-related fees | (2) | 26,250 | 178,200 |
| Tax fees | (3) | 94,500 | 50,000 |
| All other fees | |||
| Total fees | $1,742,473 | $928,340 | |
(1) Audit fees are related to the audit of our annual consolidated financial statements and of our assessment on internal control over financial reporting for the fiscal years ended March 31, 2025 and March 31, 2024. Audit fees also included the review of our Annual Report on Form 10-K for the years ended March 31, 2025 and March 31, 2024, the review of our interim consolidated financial statements included in our Quarterly Reports on Form 10-Q for the periods ended June 30, September 30, and December 31, 2024 and 2023, and the review of our Quarterly Report on Form 10-Q/A for the quarterly periods ended June 30 and September 30, 2023.
(2) Audit-related fees are related to registration statements on Form S-8 filed with the SEC, and for fiscal year 2024 audit-related fees billed by RSM US LLP are also related to the Form 10-K/A.
(3) Tax fees are related to fees associated with tax compliance and services relating to tax returns including review and filing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.